Search Results - "Kappenstein, Max"

The IL-3, IL-5, and GM-CSF common receptor beta chain mediates oncogenic activity of FLT3-ITD-positive AML by Charlet, Anne, Kappenstein, Max, Keye, Philip, Kläsener, Kathrin, Endres, Cornelia, Poggio, Teresa, Gorantla, Sivahari P., Kreutmair, Stefanie, Sänger, Jana, Illert, Anna L., Miething, Cornelius, Reth, Michael, Duyster, Justus, Rummelt, Christoph, von Bubnoff, Nikolas

“…FLT3-ITD is the most predominant mutation in AML being expressed in about one-third of AML patients and is associated with a poor prognosis. Efforts to better…”
Get full text

Treatment satisfaction of patients with psoriasis with topical therapy in a real-world setting: unmet need for higher effectiveness by Ninosu, Nadia, Hoelker, Suna, Kappenstein, Max, Buettner, Sylvia, Peitsch, Wiebke K., Schaarschmidt, Marthe-Lisa

“…Topical medication is the mainstay for treatment of mild psoriasis. However, dissatisfaction with topicals is common and rates of non-adherence are high…”
Get full text

Real-World Electronic Medical Records Data Identify Risk Factors for Myelofibrosis and Can Be Used to Validate Established Prognostic Scores by Kappenstein, Max, von Bubnoff, Nikolas

“…Myelofibrosis (MF) is a myeloproliferative neoplasia arising de novo as primary myelofibrosis (PMF) or secondary to polycythemia vera or essential…”
Get full text

Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-cell Lymphoma by Ninosu, Nadia, Melchers, Susanne, Kappenstein, Max, Booken, Nina, Hansen, Inga, Blanchard, Maël, Guenova, Emmanuella, Assaf, Chalid, Goerdt, Sergij, Nicolay, Jan P

“…Primary cutaneous T-cell lymphomas (CTCLs) are rare lymphoproliferative malignancies characterized by significant morbidity and mortality in advanced disease…”
Get full text